Contact
Please use this form to send email to PR contact of this press release:
PhotoPharmics Closes Oversubscribed $6 Million Series B Extension to Advance FDA Breakthrough Parkinson’s Device
TO:
Spokesperson
PhotoPharmics
+1 801-361-6600